Skip to main content

Table 4 Socio-demographic and clinical factors associated with glycaemic control

From: Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry

 

HbA1 < 7 (N = 294)

HbA1 ≥ 7 (N = 392)

p-value

Socio-demographic characteristics

 Age (Mean, SD; years)

62.99 (12.71)

63.24 (12.37)

.788

 Sex (N, %)

  Male

182 (45.7)

216 (54.3)

.074

  Female

112 (38.9)

176 (61.1)

 Urbanicity (N, %)

  Rural

9 (33.3)

18 (66.7)

.316

  Urban

250 (43.1)

330 (56.9)

 Marital Status (N, %)

  Married

124 (39.2)

192 (60.8)

.639

  Divorced

3 (50.0)

3 (50.0)

  Single

34 (44.4)

40 (55.6)

 Educational Level (N, %)

   ≤ 12 years of education

100 (41.7)

140 (58.3)

.643

   > 12 years of education (college or university)

30 (38.6)

43 (61.4)

 Employment status (N, %)

  Employed

34 (37.0)

58 (63.0)

.648

  Economically inactive/student

110 (42.1)

151 (57.9)

  Unemployed

25 (43.1)

33 (56.9)

Clinical characteristics

 T2DM duration (N, %)

  6 months to 5 years

97 (40.9)

140 (59.1)

.677

  6–10 years

63 (42.3)

86 (57.7)

   ≥ 10 years

134 (44.7)

166 (55.3)

 Family history of diabetes (N, %)

  No

166 (46.5)

191 (53.5)

.045

  Yes

128 (38.9)

201 (61.1)

 Dyslipidemia (N, %)

  No

115 (45.1)

140 (54.9)

.380

  Yes

179 (41.5)

252 (58.5)

 Hypertension (N, %)

  No

113 (42.0)

156 (58.0)

.752

  Yes

181 (43.4)

236 (56.6)

 Pharmacological treatment (N, %)

  Oral antidiabetic agents only

187 (40.6)

274 (59.4)

.010

  Injectable antidiabetic agents only

47 (58.0)

34 (42.0)

  Oral and injectable antidiabetic agents

44 (38.9)

69 (61.1)

 No. of antidiabetic agents (N, %)

  1

177 (43.3)

232 (56.7)

.843

  2

79 (41.4)

112 (58.6)

   ≥ 3

22 (40.0)

33 (60.0)

 BP (N, %; (mm/Hg)

   < 130/80

82 (42.1)

113 (57.9)

.892

   ≥ 130/80

116 (41.4)

164 (58.6)

 Body mass index (N, %; kg/m2)

   < 25.0

32 (48.5)

34 (51.5)

.420

  25.0–29.9

80 (44.7)

99 (55.3)

   ≥30

161 (40.9)

223 (59.1)

 LDL (N, %; mg/dl))

   < 100

143 (47.5)

158 (52.5)

.047

   ≥ 100

114 (39.3)

176 (60.7)

 HDL (N, %; mg/dl)

   > 40

191 (50.4)

188 (49.6)

<.001

   ≤ 40

74 (32.3)

155 (67.7)

 TG (N, %; mg/dl)

   < 150

184(53.2)

162 (46.8)

<.001

   ≥ 150

85 (31.3)

187 (68.8)

 Abdominal circumference (N, %; cm)

  Target not achieved

127 (41.1)

182 (58.6)

.725

  Target achieved

71 (42.8)

95 (57.2)

Lifestyle behaviors

 Smoking (N, %)

   No

117 (42.7)

157 (57.3)

.953

  Former

44 (41.5)

62 (58.5)

  Yes

69 (41.3)

98 (58.7)

 Physical activity

  No

256 (42.9)

341 (57.1)

.974

  Yes

38 (42.7)

51 (57.3)

 Alcohol consumption per day (N, %)

  0 drinks

271 (43.6)

351 (56.4)

.289

   > 1 drink

23 (35.9)

41 (64.1)

 Processed starch, 3 servings per day (N, %)

  No

156 (44.1)

198 (55.9)

.508

  Yes

158 (41.6)

194 (58.4)

 Whole grain cereals, 3 servings per day (N, %)

  No

259 (42.4)

352 (57.6)

.480

  Yes

35 (46.7)

40 (53.3)

 Consuming or cooking with vegetable oil, most days (N, %)

  No

252 (42.9)

335 (57.1)

.925

  Yes

42 (42.4)

57 (57.6)

  1. In bold if statistically significant at the p < 0.05 or p < 0.001 level
  2. BP blood pressure, LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglycerides
  3. ‡ Moderate to rigorous physical activity for at least 30 min daily, at least 3 times/week